文献速递腹部技术与安全CT

CT影像组学特征:胰腺导管腺癌患者成纤维细胞活化蛋白表达的潜在生物标志物

CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2022-04-22

本研究回顾性纳入2017年1月至2018年4月接受MDCT扫描并手术切除的152例胰腺导管腺癌患者,从术前门静脉期影像提取1409个影像组学特征,采用LASSO回归筛选特征并构建XGBoost分类器预测成纤维细胞活化蛋白(FAP)表达。分类器在训练集AUC为0.97、验证集AUC为0.75,校准和决策曲线分析表现良好,可无创预测FAP表达并可能有助于改善临床决策。

要点

  • 基于门静脉期CT影像组学的XGBoost分类器可无创预测PDAC的FAP表达,验证集AUC为0.75。
  • 按最佳FAP截断值45.71%分为FAP低表达组91例(59.87%)和高表达组61例(40.13%),低表达组生存期更长。
  • 分类器包含13个筛选出的影像组学特征,训练集AUC为0.97。

核心结论

  • 基于门静脉期CT影像组学的XGBoost分类器可无创预测PDAC患者的FAP表达,并可能有助于改善临床决策。

研究设计与样本

  • 回顾性研究,纳入连续152例接受MDCT扫描并手术切除的PDAC患者,2017年1月至2017年12月为训练集,2018年1月至2018年4月为验证集;从每例患者术前门静脉期影像提取1409个影像组学特征,采用LASSO logistic回归算法筛选最优特征并构建XGBoost分类器,通过校准、区分度和临床有用性评估性能。

诊断标准与关键数值

  • 按最佳FAP截断值45.71%将患者分为FAP低表达组(n=91;59.87%)和FAP高表达组(n=61;40.13%);XGBoost分类器包含13个筛选出的影像组学特征,训练集AUC为0.97,验证集AUC为0.75。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop and validate a radiomics model to predict fibroblast activation protein (FAP) expression in patients with pancreatic ductal adenocarcinoma (PDAC).

METHODS: This retrospective study included consecutive 152 patients with PDAC who underwent MDCT scan and surgical resection from January 2017 to December 2017 (training set) and from January 2018 to April 2018 (validation set). In the training set, 1409 portal radiomic features were extracted from each patient's preoperative imaging. Optimal features were selected using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm, whereupon the extreme gradient boosting (XGBoost) was developed using the radiomics features. The performance of the XGBoost classifier performance was assessed by its calibration, discrimination, and clinical usefulness.

RESULTS: The patients were divided into FAP-low (n = 91; 59.87%) and FAP-high (n = 61; 40.13%) groups according to the optimal FAP cutoff (45.71%). Patients in the FAP-low group showed longer survival. The XGBoost classifier comprised 13 selected radiomics features and showed good discrimination in the training set [area under the curve (AUC), 0.97] and the validation set (AUC, 0.75). It also performed well in the calibration test and decision-curve analysis, demonstrating its potential clinical value.

CONCLUSIONS: The XGBoost classifier based on CT radiomics in the portal venous phase can non-invasively predict FAP expression and may help to improve clinical decision-making in patients with PDAC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Meng, Yu, Zhu, et al. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2022. PMID: 35451626. doi:10.1007/s00261-022-03512-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。